OptimizeRx (OPRX) EBT (2010 - 2026)

OptimizeRx has disclosed EBT across 17 years of filings, most recently posting -$1.1 million for Q2 2026.

• In Q2 2026, EBT fell 163.32% year-over-year to -$1.1 million; the TTM figure through Jun 2026 stood at $6.8 million (up 173.11% YoY), while the FY2025 annual figure was $7.0 million, up 135.85% from the prior year.
• EBT came in at -$1.1 million for Q2 2026 at OptimizeRx, down from -$644000.0 in the prior quarter.
• In the past five years, EBT ranged from a high of $7.5 million in Q4 2025 to a low of -$11.7 million in Q4 2023.
• Average EBT over 5 years is -$2.8 million, with a median of -$3.4 million recorded in 2022.
• Year-over-year, EBT plunged 8790.01% in 2022 and jumped 238.36% in 2025.
• Over 5 years, EBT stood at -$325836.0 in 2022, then tumbled by 3503.04% to -$11.7 million in 2023, then jumped by 118.81% to $2.2 million in 2024, then jumped by 238.36% to $7.5 million in 2025, then tumbled by 114.67% to -$1.1 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$1.1 million in Q2 2026, -$644000.0 in Q1 2026, and $7.5 million in Q4 2025.